Primary Central Nervous System Hodgkin Lymphoma

Primary Central Nervous System Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04961515	Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma	recruiting	Phase 2	19	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Jul 31, 2025	clinicaltrials

Data updated 23 days agoSource updated Jul 31, 2025source: clinicaltrials